ICU Medical, Inc. (ICUI): Price and Financial Metrics

ICU Medical, Inc. (ICUI)

Today's Latest Price: $203.36 USD

12.39 (-5.74%)

Updated Jan 27 4:00pm

Add ICUI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 189 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ICUI Stock Summary

  • The ratio of debt to operating expenses for Icu Medical Inc is higher than it is for about merely 0.52% of US stocks.
  • With a year-over-year growth in debt of -100%, Icu Medical Inc's debt growth rate surpasses just 0% of about US stocks.
  • In terms of volatility of its share price, ICUI is more volatile than merely 6.63% of stocks we're observing.
  • Stocks that are quantitatively similar to ICUI, based on their financial statements, market capitalization, and price volatility, are SSTK, GMED, ITI, ATRI, and CCF.
  • ICUI's SEC filings can be seen here. And to visit Icu Medical Inc's official web site, go to

ICUI Stock Price Chart Interactive Chart >

Price chart for ICUI

ICUI Price/Volume Stats

Current price $203.36 52-week high $236.51
Prev. close $215.75 52-week low $158.01
Day low $202.18 Volume 205,600
Day high $213.50 Avg. volume 157,612
50-day MA $204.73 Dividend yield N/A
200-day MA $195.21 Market Cap 4.27B

ICU Medical, Inc. (ICUI) Company Bio

ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.

ICUI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$203.36$62.78 -71%

Below please find a table outlining a discounted cash flow forecast for ICUI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Icu Medical Inc ranked in the 24th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 70.67%. In terms of the factors that were most noteworthy in this DCF analysis for ICUI, they are:

  • The company's balance sheet shows it gets 100% of its capital from equity, and 0% of its capital from debt. Notably, its equity weight is greater than 95.79% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than only 0.05% of the free cash flow producing stocks we're observing.
  • ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 55.74% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ICUI, try NRC, AZN, CNC, DHR, and EDAP.

ICUI Latest News Stream

Event/Time News Detail
Loading, please wait...

ICUI Latest Social Stream

Loading social stream, please wait...

View Full ICUI Social Stream

Latest ICUI News From Around the Web

Below are the latest news stories about Icu Medical Inc that investors may wish to consider to help them evaluate ICUI as an investment opportunity.

Central Venous Catheter Market Major Players - AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation

Global Central Venous Catheter Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Central Venous Catheter Market. The study covers important knowledge that makes the analysis document a handy resource for managers,

OpenPR | January 20, 2021

ICU Medical, Inc.'s (NASDAQ:ICUI) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Most readers would already be aware that ICU Medical's (NASDAQ:ICUI) stock increased significantly by 12% over the past...

Yahoo | January 13, 2021

KeyBanc Stick to Their Buy Rating for Icu Medical By

KeyBanc Stick to Their Buy Rating for Icu Medical | January 8, 2021

ICU Medical, Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference

SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 39th Annual Healthcare Conference, held virtually January 11-14, 2021. ICU Medical’s presentation will be on Wednesday, January 13, 2021 at 8:40 a.m. PST (11:40 a.m. EST).  The presentation will be webcast live and can be accessed by going to the Company’s website at, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.About ICU Medical, Inc.ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells inn...

Yahoo | January 5, 2021

Here's Why This Under-The-Radar Value Stock Is A Long-Term Buy

This medical device company is a vital part of the backbone of hospital products utilized in the U.S. and around the world.

Yahoo | December 22, 2020

Read More 'ICUI' Stories Here

ICUI Price Returns

1-mo -5.26%
3-mo 14.38%
6-mo 10.68%
1-year 9.88%
3-year -13.08%
5-year 111.28%
YTD -5.19%
2020 14.63%
2019 -18.51%
2018 6.31%
2017 46.59%
2016 30.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9124 seconds.